176 related articles for article (PubMed ID: 27724840)
1. Body composition in HIV-infected patients receiving highly active antiretroviral therapy.
Chițu-Tișu CE; Barbu EC; Lazăr M; Bojincă M; Tudor AM; Hristea A; Abagiu AO; Ion DA; Bădărău AI
Acta Clin Belg; 2017 Feb; 72(1):55-62. PubMed ID: 27724840
[TBL] [Abstract][Full Text] [Related]
2. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
Carr A; Miller J; Eisman JA; Cooper DA
AIDS; 2001 Apr; 15(6):703-9. PubMed ID: 11371684
[TBL] [Abstract][Full Text] [Related]
3. Body composition changes in protease inhibitor-naive HIV-infected patients treated with two nucleoside reverse transcriptase inhibitors.
Tsekes G; Chrysos G; Douskas G; Paraskeva D; Mangafas N; Giannakopoulos D; Papanikolaou M; Georgiou E; Lazanas MC
HIV Med; 2002 Apr; 3(2):85-90. PubMed ID: 12010354
[TBL] [Abstract][Full Text] [Related]
4. Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women.
McDermott AY; Shevitz A; Knox T; Roubenoff R; Kehayias J; Gorbach S
Am J Clin Nutr; 2001 Nov; 74(5):679-86. PubMed ID: 11684538
[TBL] [Abstract][Full Text] [Related]
5. Impact of antiretroviral therapy on bone metabolism markers in HIV-seropositive patients.
Marques de Menezes EG; de Paula FJ; Machado AA; de Assis Pereira F; Barbosa Júnior F; Navarro AM
Bone; 2013 Nov; 57(1):62-7. PubMed ID: 23891908
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy and bone mineral measurements in HIV-infected youths.
Zuccotti G; Viganò A; Gabiano C; Giacomet V; Mignone F; Stucchi S; Manfredini V; Marinacci F; Mora S
Bone; 2010 Jun; 46(6):1633-8. PubMed ID: 20211284
[TBL] [Abstract][Full Text] [Related]
7. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
[TBL] [Abstract][Full Text] [Related]
8. Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls.
Delpierre C; Bonnet E; Marion-Latard F; Aquilina C; Obadia M; Marchou B; Massip P; Perret B; Bernard J
J Clin Densitom; 2007; 10(4):376-80. PubMed ID: 17888698
[TBL] [Abstract][Full Text] [Related]
9. Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: the Monarch randomized controlled trial.
Guaraldi G; Zona S; Cossarizza A; Vernacotola L; Carli F; Lattanzi A; Nardini G; Orlando G; Garlassi E; Termini R; Garau M
Int J STD AIDS; 2014 Mar; 25(3):207-12. PubMed ID: 24216034
[TBL] [Abstract][Full Text] [Related]
10. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
Guo FP; Yu XB; Luo L; Han Y; Qiu ZF; Zuo LY; Li YL; Yu W; Li TS
Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):649-52. PubMed ID: 20979781
[TBL] [Abstract][Full Text] [Related]
11. Aged-Related Changes in Body Composition and Association between Body Composition with Bone Mass Density by Body Mass Index in Chinese Han Men over 50-year-old.
Jiang Y; Zhang Y; Jin M; Gu Z; Pei Y; Meng P
PLoS One; 2015; 10(6):e0130400. PubMed ID: 26090818
[TBL] [Abstract][Full Text] [Related]
12. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Woodhouse AF; Gamble GD; Reid IR
Clin Endocrinol (Oxf); 2007 Aug; 67(2):270-5. PubMed ID: 17547686
[TBL] [Abstract][Full Text] [Related]
14. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
15. Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy.
Huang JS; Rietschel P; Hadigan CM; Rosenthal DI; Grinspoon S
AIDS; 2001 May; 15(8):975-82. PubMed ID: 11399979
[TBL] [Abstract][Full Text] [Related]
16. Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.
Tsai MS; Hung CC; Liu WC; Chen KL; Chen MY; Hsieh SM; Sheng WH; Sun HY; Shih TT
J Microbiol Immunol Infect; 2014 Apr; 47(2):109-15. PubMed ID: 23073318
[TBL] [Abstract][Full Text] [Related]
17. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.
Teichmann J; Stephan E; Lange U; Discher T; Friese G; Lohmeyer J; Stracke H; Bretzel RG
J Infect; 2003 May; 46(4):221-7. PubMed ID: 12799147
[TBL] [Abstract][Full Text] [Related]
18. Occurrence & predictors of osteoporosis & impact of body composition alterations on bone mineral health in asymptomatic pre-menopausal women with HIV infection.
Dutta D; Garga UC; Gadpayle AK; Bansal R; Anand A; Gaurav K; Sharma LK; Sharma N
Indian J Med Res; 2018 May; 147(5):484-495. PubMed ID: 30082573
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal analysis of bone density in human immunodeficiency virus-infected women.
Dolan SE; Kanter JR; Grinspoon S
J Clin Endocrinol Metab; 2006 Aug; 91(8):2938-45. PubMed ID: 16735489
[TBL] [Abstract][Full Text] [Related]
20. Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.
Mulligan K; Harris DR; Emmanuel P; Fielding RA; Worrell C; Kapogiannis BG; Monte D; Sleasman J; Wilson CM; Aldrovandi GM;
Clin Infect Dis; 2012 Aug; 55(3):461-8. PubMed ID: 22573848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
